The India bioreactors market is expected to reach US$ 164.8 Mn in 2027 from US$ 94.6 Mn in 2018. The market is estimated to grow with a CAGR of 6.6% from 2019-2027.
The growth of the market is driven by the factors such as increasing number of bioreactors manufacturers, speedy evolution of pharmaceutical industry and aggressive pharmaceutical & biotechnological activities. However, the market is likely to get affected due to concern of regulatory framework during the forecast period.
The industry is driven by the factors such as capabilities of cost-effective manufacturing as compared to other manufacturing economies, simplified regulatory guidelines for biotechnology industry, rising government supports through the funding, mentoring, handholding and infrastructure support and others. For instance, BIRAC has launched an Equity based fund, the fund was granted for AcE (Accelerating Entrepreneurs). Approximately USD 150,000 for promising ventures was granted to accelerate the growth of entrepreneurs in the field of biotechnology. These factors have led to the significant growth and has encouraged local players to enter the market.
The country has opportunities to work on the precision medicines to offer targeted treatment to the individual. The country currently is facing increasing number of the diseases such as diabetes, obesity and cancers and others. Therefore, innovating the precision medicine for the targeted diseases will assist to control the rising incidences of the various diseases. The capabilities of the bioreactors to design and develop the specific requirements will enable to treat the diseases of an individual. Therefore, the rising need to treat the chronic diseases with the advanced technologies will require the enormous numbers of bioreactors to increase the production.
The India bioreactors market is segmented based on product class, application and process. Bioproduction segment is anticipated to grow at a CAGR of 6.2% during the forecast period, by process. The segment is likely to experience maximum growth in the forecast period owing to the extensive production of the medicine and therapeutic products in the country. In addition, the segment is anticipated to grow significantly due to the growing numbers of the pharmaceutical companies and extensive production of generics drugs and vaccines.
| Report Attribute | Details |
|---|---|
| Market size in 2018 | US$ 94.6 Million |
| Market Size by 2027 | US$ 164.8 Million |
| CAGR (2019 - 2027) | 6.6% |
| Historical Data | 2016-2017 |
| Forecast period | 2019-2027 |
| Segments Covered |
By Product Class
|
| Regions and Countries Covered |
India
|
| Market leaders and key company profiles |
|
The India Bioreactors Market is valued at US$ 94.6 Million in 2018, it is projected to reach US$ 164.8 Million by 2027.
As per our report India Bioreactors Market, the market size is valued at US$ 94.6 Million in 2018, projecting it to reach US$ 164.8 Million by 2027. This translates to a CAGR of approximately 6.6% during the forecast period.
The India Bioreactors Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the India Bioreactors Market report:
The India Bioreactors Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The India Bioreactors Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the India Bioreactors Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For India Bioreactors Market
